BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 18657554)

  • 21. GABA(A) receptor subtype selectivity underlying anxiolytic effect of 6-hydroxyflavone.
    Ren L; Wang F; Xu Z; Chan WM; Zhao C; Xue H
    Biochem Pharmacol; 2010 May; 79(9):1337-44. PubMed ID: 20067772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The anxiolytic effect of gamma-hydroxybutyrate in the elevated plus maze is reversed by the benzodiazepine receptor antagonist, flumazenil.
    Schmidt-Mutter C; Pain L; Sandner G; Gobaille S; Maitre M
    Eur J Pharmacol; 1998 Jan; 342(1):21-7. PubMed ID: 9544788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Imidazenil: a new partial positive allosteric modulator of gamma-aminobutyric acid (GABA) action at GABAA receptors.
    Giusti P; Ducić I; Puia G; Arban R; Walser A; Guidotti A; Costa E
    J Pharmacol Exp Ther; 1993 Aug; 266(2):1018-28. PubMed ID: 8394902
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SL651498: an anxioselective compound with functional selectivity for alpha2- and alpha3-containing gamma-aminobutyric acid(A) (GABA(A)) receptors.
    Griebel G; Perrault G; Simiand J; Cohen C; Granger P; Decobert M; Françon D; Avenet P; Depoortere H; Tan S; Oblin A; Schoemaker H; Evanno Y; Sevrin M; George P; Scatton B
    J Pharmacol Exp Ther; 2001 Aug; 298(2):753-68. PubMed ID: 11454940
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anxiolytic-like effect of Carvacrol (5-isopropyl-2-methylphenol) in mice: involvement with GABAergic transmission.
    Melo FH; Venâncio ET; de Sousa DP; de França Fonteles MM; de Vasconcelos SM; Viana GS; de Sousa FC
    Fundam Clin Pharmacol; 2010 Aug; 24(4):437-43. PubMed ID: 19909350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kaempferol from the leaves of Apocynum venetum possesses anxiolytic activities in the elevated plus maze test in mice.
    Grundmann O; Nakajima J; Kamata K; Seo S; Butterweck V
    Phytomedicine; 2009 Apr; 16(4):295-302. PubMed ID: 19303276
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological studies on synthetic flavonoids: comparison with diazepam.
    Griebel G; Perrault G; Tan S; Schoemaker H; Sanger DJ
    Neuropharmacology; 1999 Jul; 38(7):965-77. PubMed ID: 10428415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GABA A receptors as in vivo substrate for the anxiolytic action of valerenic acid, a major constituent of valerian root extracts.
    Benke D; Barberis A; Kopp S; Altmann KH; Schubiger M; Vogt KE; Rudolph U; Möhler H
    Neuropharmacology; 2009 Jan; 56(1):174-81. PubMed ID: 18602406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chlorogenic acid, a polyphenol from Prunus domestica (Mirabelle), with coupled anxiolytic and antioxidant effects.
    Bouayed J; Rammal H; Dicko A; Younos C; Soulimani R
    J Neurol Sci; 2007 Nov; 262(1-2):77-84. PubMed ID: 17698084
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intra-periaqueductal gray matter injections of midazolam fail to alter anxiety in plus-maze experienced mice.
    dos Reis LM; Canto-de-Souza A
    Brain Res; 2008 Sep; 1231():93-102. PubMed ID: 18621039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 6,3'-Dinitroflavone is a low efficacy modulator of GABA(A) receptors.
    Furtmueller R; Furtmueller B; Ramerstorfer J; Paladini AC; Wasowski C; Marder M; Huck S; Sieghart W
    Eur J Pharmacol; 2008 Sep; 591(1-3):142-6. PubMed ID: 18639544
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interactions between LY354740, a group II metabotropic agonist and the GABA(A)-benzodiazepine receptor complex in the rat elevated plus-maze.
    Ferris P; Seward E; Dawson GR
    J Psychopharmacol; 2001 Jun; 15(2):76-82. PubMed ID: 11448091
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New evidence that the pharmacological effects of benzodiazepine receptor ligands can be associated with activities at different BZ (omega) receptor subtypes.
    Griebel G; Perrault G; Letang V; Granger P; Avenet P; Schoemaker H; Sanger DJ
    Psychopharmacology (Berl); 1999 Sep; 146(2):205-13. PubMed ID: 10525757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Properties of recombinant gamma-aminobutyric acid A receptor isoforms containing the alpha 5 subunit subtype.
    Burgard EC; Tietz EI; Neelands TR; Macdonald RL
    Mol Pharmacol; 1996 Jul; 50(1):119-27. PubMed ID: 8700104
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of the electrophysiological and pharmacological effects of 4-iodo-2,6-diisopropylphenol, a propofol analogue devoid of sedative-anaesthetic properties.
    Sanna E; Motzo C; Usala M; Serra M; Dazzi L; Maciocco E; Trapani G; Latrofa A; Liso G; Biggio G
    Br J Pharmacol; 1999 Mar; 126(6):1444-54. PubMed ID: 10217539
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Behavioral effects of agents active at the gamma-aminobutyric acid receptor complex in the staircase paradigm.
    Weizman R; Paz L; Peter Y; Toren P; Pick CG
    Brain Res; 2001 May; 901(1-2):137-42. PubMed ID: 11368960
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 5-ethoxymethyl-7-fluoro-3-oxo-1,2,3,5-tetrahydrobenzo[4,5]imidazo[1,2a]pyridine-4-N-(2-fluorophenyl)carboxamide (RWJ-51204), a new nonbenzodiazepine anxiolytic.
    Dubinsky B; Vaidya AH; Rosenthal DI; Hochman C; Crooke JJ; DeLuca S; DeVine A; Cheo-Isaacs CT; Carter AR; Jordan AD; Reitz AB; Shank RP
    J Pharmacol Exp Ther; 2002 Nov; 303(2):777-90. PubMed ID: 12388665
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Limiting activity at beta1-subunit-containing GABAA receptor subtypes reduces ataxia.
    Gee KW; Tran MB; Hogenkamp DJ; Johnstone TB; Bagnera RE; Yoshimura RF; Huang JC; Belluzzi JD; Whittemore ER
    J Pharmacol Exp Ther; 2010 Mar; 332(3):1040-53. PubMed ID: 19940102
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Behavioral effects of diazepam in the murine plus-maze: flumazenil antagonism of enhanced head dipping but not the disinhibition of open-arm avoidance.
    Dalvi A; Rodgers RJ
    Pharmacol Biochem Behav; 1999 Apr; 62(4):727-34. PubMed ID: 10208379
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RP 59037 and RP 60503: anxiolytic cyclopyrrolone derivatives with low sedative potential. interaction with the gamma-aminobutyric acidA/benzodiazepine receptor complex and behavioral effects in the rodent.
    Doble A; Canton T; Dreisler S; Piot O; Boireau A; Stutzmann JM; Bardone MC; Rataud J; Roux M; Roussel G
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1213-26. PubMed ID: 8103792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.